What do analysts expect the price target to be for EXELON CORP (EXC)?
26 analysts have analysed EXC and the average price target is 50.5 USD. This implies a price increase of 0.42% is expected in the next year compared to the current price of 50.29.
NASDAQ:EXC • US30161N1019
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXELON CORP (EXC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-03-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-03-04 | Keybanc | Maintains | Underweight -> Underweight |
| 2026-02-20 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-13 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-02-13 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-27 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-22 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-28 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-15 | Keybanc | Maintains | Underweight -> Underweight |
| 2025-10-15 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-10 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-16 | Keybanc | Maintains | Underweight -> Underweight |
| 2025-07-11 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.727B 13.89% | 23.028B 5.99% | 24.258B 5.34% | 25.375B 4.60% | 26.202B 3.26% | 27.062B 3.28% | 28.176B 4.12% | 29.452B 4.53% | |
| EBITDA YoY % growth | 7.519B 9.77% | 7.903B 5.11% | 8.788B 11.20% | 9.624B 9.51% | 10.362B 7.67% | 11.214B 8.22% | 12.284B 9.54% | 13.088B 6.55% | |
| EBIT YoY % growth | 4.013B 20.98% | 4.307B 7.33% | 5.145B 19.46% | 5.528B 7.44% | 5.937B 7.40% | 6.327B 6.57% | 6.877B 8.69% | 7.345B 6.81% | |
| Operating Margin | 18.47% | 18.70% | 21.21% | 21.79% | 22.66% | 23.38% | 24.41% | 24.94% | |
| EPS YoY % growth | 2.38 5.31% | 2.50 5.04% | 2.76 10.40% | 2.88 4.29% | 3.08 6.86% | 3.29 7.12% | 3.50 6.31% | 3.74 6.70% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.87 -5.59% | 0.49 26.90% | 0.89 3.35% | 0.63 6.99% | 0.92 6.40% | 0.53 6.12% | 0.90 1.70% | 0.69 9.60% |
| Revenue Q2Q % growth | 7.302B 8.76% | 4.969B -8.44% | 7.156B 6.73% | 5.888B 8.80% | 8.313B 13.85% | 3.58B -27.95% | 8.002B 11.82% | 5.886B -0.03% |
| EBITDA Q2Q % growth | 2.687B 10.03% | 2.126B -22.15% | 2.694B -36.15% | N/A | 1.76B -34.50% | 1.551B -27.05% | 1.729B -35.82% | N/A |
| EBIT Q2Q % growth | 1.741B 13.27% | 880.71M -4.79% | 1.559B 3.93% | 1.197B 1.18% | 1.858B 6.72% | 800.02M -9.16% | 1.788B 14.69% | 1.315B 9.86% |
All data in USD
26 analysts have analysed EXC and the average price target is 50.5 USD. This implies a price increase of 0.42% is expected in the next year compared to the current price of 50.29.
EXELON CORP (EXC) will report earnings on 2026-04-29, before the market open.
The consensus EPS estimate for the next earnings of EXELON CORP (EXC) is 0.87 USD and the consensus revenue estimate is 7.30B USD.
The expected long term growth rate for EXELON CORP (EXC) is 3.46%.